A Single-Celled Organism Has a Functional Opioid Receptor — Predating Nervous Systems

The single-celled protozoan Tetrahymena has a naloxone-reversible opioid receptor that regulates phagocytosis, proving opioid signaling predates the evolution of nervous systems.

Chiesa, R et al.·The Journal of eukaryotic microbiology·1993·Preliminary Evidencein-vitro
RPEP-00260In VitroPreliminary Evidence1993RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Tetrahymena has a functional opioid receptor that inhibits phagocytosis. Morphine most potent, beta-endorphin second. Naloxone-reversible. Receptor predates nervous systems.

Key Numbers

How They Did This

Phagocytosis assays in Tetrahymena with various mammalian opioid agonists and antagonists. Intrinsic activity and potency rankings determined.

Why This Research Matters

Finding opioid receptors in a single-celled organism means this signaling system is far more ancient than previously thought. It evolved long before there were nervous systems or pain perception.

The Bigger Picture

If even single-celled organisms use opioid-like signaling, this system is far more ancient and fundamental than pain control. It likely evolved for basic cell-to-cell communication and survival behaviors, only later being co-opted for pain and reward in animals with nervous systems.

What This Study Doesn't Tell Us

Single-celled organism study. The Tetrahymena 'opioid receptor' may not be structurally identical to mammalian opioid receptors. Pharmacological similarity does not prove molecular identity.

Questions This Raises

  • ?Is the Tetrahymena opioid receptor molecularly related to mammalian opioid receptors?
  • ?What survival advantage did opioid signaling provide to single-celled organisms?

Trust & Context

Key Stat:
Billion+ years old Opioid receptor function in a single-celled organism means this signaling system predates multicellular life and nervous systems
Evidence Grade:
Preliminary — in vitro pharmacological study. Shows functional opioid-like signaling but the receptor may not be structurally identical to mammalian opioid receptors.
Study Age:
Published in 1993 (33 years ago). The concept of opioid signaling in primitive organisms has been supported by subsequent studies.
Original Title:
Pharmacological characterization of an opioid receptor in the ciliate Tetrahymena.
Published In:
The Journal of eukaryotic microbiology, 40(6), 800-4 (1993)
Database ID:
RPEP-00260

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How can an organism without a brain have opioid receptors?

Opioid receptors are proteins on cell surfaces that detect chemical signals. They don't require a brain — they evolved as a basic cell communication tool long before nervous systems existed. Pain perception came much later.

What does this tell us about opioid drugs?

It suggests opioid signaling is one of the most ancient and fundamental biological communication systems. This helps explain why opioid receptors are found throughout the body, not just in the brain — they have roles far beyond pain.

Read More on RethinkPeptides

Cite This Study

RPEP-00260·https://rethinkpeptides.com/research/RPEP-00260

APA

Chiesa, R; Silva, W I; Renaud, F L. (1993). Pharmacological characterization of an opioid receptor in the ciliate Tetrahymena.. The Journal of eukaryotic microbiology, 40(6), 800-4.

MLA

Chiesa, R, et al. "Pharmacological characterization of an opioid receptor in the ciliate Tetrahymena.." The Journal of eukaryotic microbiology, 1993.

RethinkPeptides

RethinkPeptides Research Database. "Pharmacological characterization of an opioid receptor in th..." RPEP-00260. Retrieved from https://rethinkpeptides.com/research/chiesa-1993-pharmacological-characterization-of-an

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.